Gene delivery to differentiated neurotypic cells with RGD and HIV Tat peptide functionalized polymeric nanoparticles

Biomaterials

Volumn 27, Issue 29, 2006, Pages 5143-5150

  Suk, Jung Soo ^a   Suh, Junghae ^a   Choy, Kokleong ^a   Lai, Samuel K ^b   Fu, Jie ^b   Hanes, Justin ^a,b  

^a Johns Hopkins University   (United States)

^b Johns Hopkins University   (United States)

Author keywords

CNS diseases; Gene therapy; Polyethylenimine (PEI); Polymers

Indexed keywords

CNS DISEASES; ENDOSOMES; GENE THERAPY; POLYETHYLENIMINE (PEI);

AMINO ACIDS; DISEASES; DNA; GENES; NEUROLOGY;

CELLS;

ARGINYLGLYCYLASPARTIC ACID; MACROGOL; NANOPARTICLE; PLASMID DNA; POLYETHYLENEIMINE; POLYMER; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ARTICLE; CELL DIFFERENTIATION; ENDOSOME; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NERVE CELL; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

BIOCOMPATIBLE MATERIALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; GENE PRODUCTS, TAT; GENE TRANSFER TECHNIQUES; HIV; HUMANS; NEURONS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33745226168     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.05.013     Document Type: Article

References (60)

1. Burton E.A., Glorioso J.C., and Fink D.J. Gene therapy progress and prospects: Parkinson's disease. Gene Ther 10 20 (2003) 1721-1727
2. Hurelbrink C.B., and Barker R.A. The potential of GDNF as a treatment for Parkinson's disease-commentary. Exp Neurol 185 1 (2004) 1-6
3. Corti O., Sanchez-Capelo A., Colin P., Hanoun N., Hamon M., and Mallet J. Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease. Proc Natl Acad Sci USA 96 21 (1999) 12120-12125
4. Chen X.W., Liu W.G., Yang G.Y., Liu Z.G., Smith S., Calne D.B., et al. Protective effects of intracerebral adenoviral-mediated GDNF gene transfer in a rat model of Parkinson's disease. Parkinsonism Relat Disord 10 1 (2003) 1-7
5. Lu Y.Y., Wang L.J., Muramatsu S., Ikeguchi K., Fujimoto K., Okada T., et al. Intramuscular injection of AAV-GDNF results in sustained expression of transgenic GDNF, and its delivery to spinal motoneurons by retrograde transport. Neurosci Res 45 1 (2003) 33-40
6. Horellou P., and Mallet J. Gene therapy for Parkinson's disease. Molec Neurobiol 15 2 (1997) 241-256
7. Luo D., and Saltzman W.M. Synthetic DNA delivery systems. Nat Biotechnol 18 1 (2000) 33-37
8. Pack D.W., Hoffman A.S., Pun S., and Stayton P.S. Design and development of polymers for gene delivery. Nat Rev Drug Discov 4 7 (2005) 581-593
9. Berry M., Barrett L., Seymour L., Baird A., and Logan A. Gene therapy for central nervous system repair. Curr Opin Molec Ther 3 4 (2001) 338-349
10. Guerra-Crespo M., Charli J.L., Rosales-Garcia V.H., Pedraza-Alva G., and Perez-Martinez L. Polyethylenimine improves the transfection efficiency of primary cultures of post-mitotic rat fetal hypothalamic neurons. J Neurosci Methods 127 2 (2003) 179-192
11. Wu K., Meyers C.A., Bennett J.A., King M.A., Meyer E.M., and Hughes J.A. Polyethylenimine-mediated NGF gene delivery protects transected septal cholinergic neurons. Brain Res 1008 2 (2004) 284-287
12. Gharwan H., Wightman L., Kircheis R., Wagner E., and Zatloukal K. Nonviral gene transfer into fetal mouse livers (a comparison between the cationic polymer PEI and naked DNA). Gene Ther 10 9 (2003) 810-817
13. Zaric V., Weltin D., Erbacher P., Remy J.S., Behr J.P., and Stephan D. Effective polyethylenimine-mediated gene transfer into human endothetial cells. J Gene Med 6 2 (2004) 176-184
14. Boussif O., Lezoualch F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 92 16 (1995) 7297-7301
15. Godbey W.T., Barry M.A., Saggau P., Wu K.K., and Mikos A.G. Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. J Biomed Mater Res 51 3 (2000) 321-328
16. Zou S.M., Erbacher P., Remy J.S., and Behr J.P. Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse. J Gene Med 2 2 (2000) 128-134
17. Suh J., Wirtz D., and Hanes J. Real-time intracellular transport of gene nanocarriers studied by multiple particle tracking. Biotechnol Progr 20 2 (2004) 598-602
18. Suh J., Wirtz D., and Hanes J. Efficient active transport of gene nanocarriers to the cell nucleus. Proc Natl Acad Sci USA 100 7 (2003) 3878-3882
19. Suk JS, Suh J, Lai SK, Hanes J. Quantifying the intracellular transport of viral and nonviral gene vectors in primary neurons. Submitted for publication.
20. Behr J.P. The proton sponge: a trick to enter cells the viruses did not exploit. Chimia 51 1-2 (1997) 34-36
21. Sonawane N.D., Szoka Jr. F.C., and Verkman A.S. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem 278 45 (2003) 44826-44831
22. Forrest M.L., and Pack D.W. On the kinetics of polyplex endocytic trafficking: implications for gene delivery vector design. Molec Ther 6 1 (2002) 57-66
23. Hara H., Ohta M., Ohta K., Kuno S., and Adachi T. Increase of antioxidative potential by tert-butylhydroquinone protects against cell death associated with 6-hydroxydopamine-induced oxidative stress in neuroblastoma SH-SY5Y cells. Molec Brain Res 119 2 (2003) 125-131
24. Ben-Shachar D., Zuk R., Gazawi H., and Ljubuncic P. Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders. Biochem Pharmacol 67 10 (2004) 1965-1974
25. Simpson P.B., Bacha J.L., Palfreyman E.L., Woollacott A.J., McKernan R.M., and Kerby J. Retinoic acid-evoked differentiation of neuroblastoma cells predominates over growth factor stimulation: an automated image capture and quantitation approach to neuritogenesis. Anal Biochem 298 2 (2001) 163-169
26. Almeida A., Bolanos J.P., and Moreno S. Cdh1/Hct1-APC is essential for the survival of postmitotic neurons. J Neurosci 25 36 (2005) 8115-8121
27. Liu G., Li D., Pasumarthy M.K., Kowalczyk T.H., Gedeon C.R., Hyatt S.L., et al. Nanoparticles of compacted DNA transfect postmitotic cells. J Biol Chem 278 35 (2003) 32578-32586
28. Snyder S.L., and Sobocinski P.Z. Improved 2,4,6-trinitrobenzenesulfonic acid method for determination of amines. Anal Biochem 64 1 (1975) 284-288
29. Buckley C.D., Pilling D., Henriquez N.V., Parsonage G., Threlfall K., Scheel-Toellner D., et al. RGD peptides induce apoptosis by direct caspase-3 activation. Nature 397 6719 (1999) 534-539
30. Tyllianakis P.E., Kakabakos S.E., Evangelatos G.P., and Ithakissios D.S. Direct colorimetric determination of solid-supported functional groups and ligands using bicinchoninic acid. Anal Biochem 219 2 (1994) 335-340
31. Watson P., Jones A.T., and Stephens D.J. Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells. Adv Drug Deliv Rev 57 1 (2005) 43-61
32. Florea B.I., Meaney C., Junginger H.E., and Borchard G. Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures. AAPS Pharmsci 4 3 (2002) E12
33. Abdallah B., Hassan A., Benoist C., Goula D., Behr J.P., and Demeneix B.A. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gene Ther 7 16 (1996) 1947-1954
34. Horbinski C., Stachowiak M.K., Higgins D., and Finnegan S.G. Polyethylenimine-mediated transfection of cultured postmitotic neurons from rat sympathetic ganglia and adult human retina. BMC Neurosci 2 1 (2001) 2
35. Cryan S.A., and O'Driscoll C.M. Mechanistic studies on nonviral gene delivery to the intestine using in vitro differentiated cell culture models and an in vivo rat intestinal loop. Pharm Res 20 4 (2003) 569-575
36. Matsui H., Johnson L.G., Randell S.H., and Boucher R.C. Loss of binding and entry of liposome-DNA complexes decreases transfection efficiency in differentiated airway epithelial cells. J Biol Chem 272 2 (1997) 1117-1126
37. Medeiros G.F., Mendes A., Castro R.A.B., Bau E.C., Nader H.B., and Dietrich C.P. Distribution of sulfated glycosaminoglycans in the animal kingdom: widespread occurrence of heparin-like compounds in invertebrates. Biochim Biophys Acta-Gen Subjects 1475 3 (2000) 287-294
38. Margolis R.K., Salton S.R., and Margolis R.U. Effects of nerve growth factor-induced differentiation on the heparan sulfate of PC12 pheochromocytoma cells and comparison with developing brain. Arch Biochem Biophys 257 1 (1987) 107-114
39. Ogris M., Walker G., Blessing T., Kircheis R., Wolschek M., and Wagner E. Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J Control Rel 91 1-2 (2003) 173-181
40. Kunath K., Merdan T., Hegener O., Haberlein H., and Kissel T. Integrin targeting using RGD-PEI conjugates for in vitro gene transfer. J Gene Med 5 7 (2003) 588-599
41. Schaffer D.V., and Lauffenburger D.A. Optimization of cell surface binding enhances efficiency and specificity of molecular conjugate gene delivery. J Biol Chem 273 43 (1998) 28004-28009
42. Kursa M., Walker G.F., Roessler V., Ogris M., Roedl W., Kircheis R., et al. Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. Bioconjugate Chem 14 1 (2003) 222-231
43. Sakhalkar H.S., Dalal M.K., Salem A.K., Ansari R., Fu A., Kiani M.F., et al. Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo. Proc Natl Acad Sci USA 100 26 (2003) 15895-15900
44. Medina-Kauwe L.K. Endocytosis of adenovirus and adenovirus capsid proteins. Adv Drug Deliv Rev 55 11 (2003) 1485-1496
45. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 12 (1996) 697-715
46. Harvie P., Dutzar B., Galbraith T., Cudmore S., O'Mahony D., Anklesaria P., et al. Targeting of lipid-protamine-DNA (LPD) lipopolyplexes using RGD motifs. J Liposome Res 13 3-4 (2003) 231-247
47. Wittekindt C., Bottger M., Holtje H.D., Schafer-Korting M., Cartier R., and Haberland A. Integrin-specificity of the cyclic Arg-Gly Asp motif and its role in integrin targeted gene transfer. Biotechnol Appl Biochem (2004)
48. Colin M., Harbottle R.P., Knight A., Kornprobst M., Cooper R.G., Miller A.D., et al. Liposomes enhance delivery and expression of an RGD-oligolysine gene transfer vector in human tracheal cells. Gene Ther 5 11 (1998) 1488-1498
49. Arnaout M.A., Goodman S.L., and Xiong J.P. Coming to grips with integrin binding to ligands. Curr Opin Cell Biol 14 5 (2002) 641-651
50. Wickham T.J., Mathias P., Cheresh D.A., and Nemerow G.R. Integrin-alpha-V-beta-3 and integrin-alpha-V-beta-5 promote adenovirus internalization but not virus attachment. Cell 73 2 (1993) 309-319
51. Li E., Stupack D., Klemke R., Cheresh D.A., and Nemerow G.R. Adenovirus endocytosis via alpha(v) integrins requires phosphoinositide-3-OH kinase. J Virol 72 3 (1998) 2055-2061
52. Ziegler A., and Seelig J. Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: binding mechanism and thermodynamic parameters. Biophys J 86 1 (2004) 254-263
53. Tamura M., Natori K., Kobayashi M., Miyamura T., and Takeda N. Genogroup II noroviruses efficiently bind to heparan sulfate proteoglycan associated with the cellular membrane. J Virol 78 8 (2004) 3817-3826
54. Vives E. Cellular uptake of the Tat peptide: an endocytosis mechanism following ionic interactions. J Molec Recogn 16 5 (2003) 265-271
55. Jarver P., and Langel U. The use of cell-penetrating peptides as a tool for gene regulation. Drug Discov Today 9 9 (2004) 395-402
56. Wang K., Guan T.L., Cheresh D.A., and Nemerow G.R. Regulation of adenovirus membrane penetration by the cytoplasmic tail of integrin beta 5. J Virol 74 6 (2000) 2731-2739
57. Ogris M., Brunner S., Schuller S., Kircheis R., and Wagner E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 6 4 (1999) 595-605
58. Fu J., Fiegel J., Krauland E., and Hanes J. New polymeric carriers for controlled drug delivery following inhalation or injection. Biomaterials 23 22 (2002) 4425-4433
59. Fiegel J., Fu J., and Hanes J. Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs. J Control Rel 96 3 (2004) 411-423
60. Soundara Manickam D., Bisht H.S., Wan L., Mao G., and Oupicky D. Influence of TAT-peptide polymerization on properties and transfection activity of TAT/DNA polyplexes. J Control Rel 102 1 (2005) 293-306